Hancock Whitney Corp has trimmed its holdings in CVS Health Corporation by 3.5% in the first quarter, selling 314 shares to bring its remaining total to 8,609. This change, as reported by HoldingsChannel.com, values the investment at $583,000.
Hancock Whitney Corp Cuts Holdings in CVS Health Corporation $CVS

Key Takeaways:
- Hancock Whitney Corp reduced its CVS Health stake by 3.5%.
- 314 shares were sold in the first quarter.
- The institutional investor now holds 8,609 CVS shares.
- This remaining investment is valued at $583,000.
- Data was sourced from HoldingsChannel.com and reported by Watch List News.
Overview
Hancock Whitney Corp recently adjusted its portfolio by reducing its holdings in CVS Health Corporation. The move is part of a slight shift in strategy by the institutional investor, as indicated by recent filings.
Details of the Reduction
In the first quarter, Hancock Whitney Corp sold 314 shares of CVS Health stock, representing a 3.5% decrease in its overall position. According to the filing, the investor now owns 8,609 shares in the pharmacy operator, reflecting a total value of approximately $583,000.
Significance for Stakeholders
Although the sale is minor in percentage terms, it captures the attention of investors observing institutional activity in CVS Health. Such adjustments can signal a variety of motivations, from portfolio rebalancing to broader market conditions.
Data Sources and References
Information regarding Hancock Whitney Corp’s realigned position stemmed from filings accessible on HoldingsChannel.com. Watch List News originally published the story on September 7, 2025, citing the same source data for reference.
Table: CVS Health Holdings for Hancock Whitney Corp (Q1)
Quarter | Shares Sold | Remaining Shares | Estimated Value |
---|---|---|---|
Q1 2025 | 314 | 8,609 | $583,000 |
This recorded shift underscores how even modest transactions can reflect evolving strategies within institutional portfolios.